Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

Apelin

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-06-26 — Hormonal dimorphism in sarcopenia disease.: Narrative review (no new primary data) frames apelin as a female-predominant sarcopenia axis disrupted by menopausal estrogen loss, arguing for sex-stratified therapy alongside insulin and oxytocin pathways. [mechanism-plausible] (novelty: 3)

Open questions

Related

Contributing findings

pubmed review mechanism-plausible
Hormonal dimorphism in sarcopenia disease.
26-jun-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18